Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water

被引:586
作者
Li, Ying [1 ]
Fletcher, Tony [2 ]
Mucs, Daniel [3 ]
Scott, Kristin [4 ]
Lindh, Christian H. [4 ]
Tallving, Pia [4 ]
Jakobsson, Kristina [1 ,4 ]
机构
[1] Univ Gothenburg, Dept Publ Hlth & Community Med, Div Occupat & Environm Med, Gothenburg, Sweden
[2] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London, England
[3] Karolinska Inst, Swetox, Unit Toxicol Sci Sodertalje, Stockholm, Sweden
[4] Lund Univ, Dept Lab Med, Div Occupat & Environm Med, Lund, Sweden
基金
瑞典研究理事会;
关键词
PERFLUOROALKYL ACIDS; SERUM CONCENTRATIONS; ELIMINATION; URINE; LIFE;
D O I
10.1136/oemed-2017-104651
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Municipal drinking water contaminated with perfluorinated alkyl acids had been distributed to one-third of households in Ronneby, Sweden. The source was firefighting foam used in a nearby airfield since the mid-1980s. Clean water was provided from 16 December 2013. Objective To determine the rates of decline in serum perfluorohexane sulfonate (PFHxS), perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA), and their corresponding half-lives. Methods Up to seven blood samples were collected between June 2014 and September 2016 from 106 participants (age 4-84 years, 53% female). Results Median initial serum concentrations were PFHxS, 277 ng/mL (range 12-1660); PFOS, 345 ng/mL (range 24-1500); and PFOA, 18 ng/mL (range 2,4-92). The covariate-adjusted average rates of decrease in serum were PFHxS, 13% per year (95% CI 12% to 15%); PFOS, 20% per year (95% CI 19% to 22%); and PFOA, 26% per year (95% CI 24% to 28%). The observed data are consistent with a first-order elimination model. The mean estimated half-life was 5.3 years (95% CI 4.6 to 6.0) for PFHxS, 3,4 years (95% CI 3,1 to 3,7) for PFOS and 2.7 years (95% CI 2.5 to 2.9) for PFOA. The interindividual variation of half-life was around threefold when comparing the 5th and 95th percentiles. There was a marked sex difference with more rapid elimination in women for PFHxS and PFOS, but only marginally for PFOA. Conclusions The estimated half-life for PFHxS was considerably longer than for PFOS and PFOA, For PFHxS and PFOS, the average half-life is shorter than the previously published estimates. For PFOA the half-life is in line with the range of published estimates.
引用
收藏
页码:46 / 51
页数:6
相关论文
共 22 条
[11]   Blood serum concentrations of perfluorinated compounds in men from Greenlandic Inuit and European populations [J].
Lindh, Christian H. ;
Rylander, Lars ;
Toft, Gunnar ;
Axmon, Anna ;
Rignell-Hydbom, Anna ;
Giwercman, Aleksander ;
Pedersen, Henning S. ;
Goalczyk, Katarzyna ;
Ludwicki, Jan K. ;
Zvyezday, Valentyna ;
Vermeulen, Roel ;
Lenters, Virissa ;
Heederik, Dick ;
Bonde, Jens Peter ;
Jonsson, Bo A. G. .
CHEMOSPHERE, 2012, 88 (11) :1269-1275
[12]   Evaluation and prediction of pharmacokinetics of PFOA and PFOS in the monkey and human using a PBPK model [J].
Loccisano, Anne E. ;
Campbell, Jerry L., Jr. ;
Andersen, Melvin E. ;
Clewell, Harvey J., III .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2011, 59 (01) :157-175
[13]  
MiraIles-Marco A, 2015, ENVIRON INT, V77, P148, DOI [10.1016/j.envint.2015., 10.1016/j.envint.2015.02.002]
[14]   Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers [J].
Olsen, Geary W. ;
Burris, Jean M. ;
Ehresman, David J. ;
Froehlich, John W. ;
Seacat, Andrew M. ;
Butenhoff, John L. ;
Zobel, Larry R. .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2007, 115 (09) :1298-1305
[15]   Temporal Trends of Perfluoroalkyl Concentrations in American Red Cross Adult Blood Donors, 2000-2010 [J].
Olsen, Geary W. ;
Lange, Cleston C. ;
Ellefson, Mark E. ;
Mair, David C. ;
Church, Timothy R. ;
Goldberg, Corinne L. ;
Herron, Ross M. ;
Medhdizadehkashi, Zahra ;
Nobiletti, John B. ;
Rios, Jorge A. ;
Reagen, William K. ;
Zobel, Larry R. .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2012, 46 (11) :6330-6338
[16]   A comparison of the pharmacokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, and humans [J].
Olsen, Geary W. ;
Chang, Shu-Ching ;
Noker, Patricia E. ;
Gorman, Gregory S. ;
Ehresman, David J. ;
Lieder, Paul H. ;
Butenhoff, John L. .
TOXICOLOGY, 2009, 256 (1-2) :65-74
[17]  
Robinson GK., 1991, Statistical Science, V6, P15, DOI [10.1214/ss/1177011926, DOI 10.1214/SS/1177011926]
[18]   Tracking the Pathways of Human Exposure to Perfluorocarboxylates [J].
Vestergren, Robin ;
Cousins, Ian T. .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2009, 43 (15) :5565-5575
[19]   Differences in the isomer composition of perfluoroctanesulfonyl (PFOS) derivatives [J].
Vyas, Sandhya M. ;
Kania-Korwel, Izabela ;
Lehmler, Hans-Joachim .
JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART A-TOXIC/HAZARDOUS SUBSTANCES & ENVIRONMENTAL ENGINEERING, 2007, 42 (03) :249-255
[20]   Enhanced Elimination of Perfluorooctane Sulfonic Acid by Menstruating Women: Evidence from Population-Based Pharmacokinetic Modeling [J].
Wong, Fiona ;
MacLeod, Matthew ;
Mueller, Jochen F. ;
Cousins, Ian T. .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2014, 48 (15) :8807-8814